Compare ATYR & SGA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ATYR | SGA |
|---|---|---|
| Founded | 2005 | 1986 |
| Country | United States | United States |
| Employees | 58 | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Broadcasting |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 51.7M | 56.6M |
| IPO Year | N/A | 1994 |
| Metric | ATYR | SGA |
|---|---|---|
| Price | $0.51 | $9.34 |
| Analyst Decision | Hold | |
| Analyst Count | 9 | 0 |
| Target Price | ★ $3.67 | N/A |
| AVG Volume (30 Days) | ★ 1.0M | 12.8K |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 9.05% |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $124,829,000.00 |
| Revenue This Year | N/A | $6.74 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.65 |
| 52 Week Low | $0.40 | $8.24 |
| 52 Week High | $6.50 | $13.51 |
| Indicator | ATYR | SGA |
|---|---|---|
| Relative Strength Index (RSI) | 50.90 | 57.73 |
| Support Level | $0.46 | $8.26 |
| Resistance Level | $0.59 | $9.42 |
| Average True Range (ATR) | 0.03 | 0.31 |
| MACD | 0.00 | 0.08 |
| Stochastic Oscillator | 79.50 | 79.37 |
aTyr Pharma Inc is a clinical-stage biotechnology company focused on developing therapies for fibrosis and inflammatory conditions. Its research leverages tRNA synthetase biology to identify potential therapeutic targets. The company's discovery platform uses a proprietary library of domains derived from tRNA synthetases to explore signaling pathways. Its flagship clinical candidate, efzofitimod, is a novel biologic immunomodulatory in development for the treatment of interstitial lung disease (ILD).
Saga Communications Inc is a broadcast company engaged in acquiring, developing, and operating broadcast properties. The company's objective is to operate top billing radio stations in mid-sized markets. It derives a majority of its revenue from the sale of advertising for broadcast on its stations.